Xiangsheng Kong
President Assistant, R&D Department General Manager
Livzon Pharmaceutical Group
Personal Profile
Main Achievements：
Kong Xiangsheng joined Livzon Pharmaceutical Group in 2002. Currently, he holds the post of Assistant to the President of Livzon Pharmaceutical Group and also a member of the Editorial Board of the Chinese Journal of Clinical Pharmacology sponsored by the Chinese Pharmaceutical Association.
Present Position: Assistant to the President of Livzon Pharmaceutical Group, General Manager of Research and Development Department of Livzon Headquarters, and Deputy Director of Livzon Pharmaceutical Factory
Work Experience:From 2015 till now as Assistant to the President of Livzon Pharmaceutical Group, General Manager of Research and Development Department of Livzon Headquarters, and Factory Deputy Director of Livzon Pharmaceutical
Since he started working at the Group, Mr. Kong has taken on a number of different roles in production and R&D departments, and gained a wealth of basic knowledge on production technology. In his roles, he ever held responsibility for marketing Shenqi Fuzheng Injection; conducting negotiation and assessment for major projects of new drugs such as Ilaprazole and Gemifloxacin; advancing the establishment and operation of the intellectual property departments at the Joincare Pharmaceutical Group Industry Co., Ltd. and its subsidiary Livzon Pharmaceutical Group; carrying out R&D of various products like Shenqi Fuzheng Injection and Yilian (Ilaprazole Enteric-Coated Tablets). Meanwhile, he also participated in the research and development of the Ilaprazole injection which is China's first and world's sixth proton pump inhibitor. Now, this product has successfully obtained the production approval and gone on sale.
Kong Xiangsheng joined Livzon Pharmaceutical Group in 2002. Currently, he holds the post of Assistant to the President of Livzon Pharmaceutical Group and also a member of the Editorial Board of the Chinese Journal of Clinical Pharmacology sponsored by the Chinese Pharmaceutical Association.
Present Position: Assistant to the President of Livzon Pharmaceutical Group, General Manager of Research and Development Department of Livzon Headquarters, and Deputy Director of Livzon Pharmaceutical Factory
Work Experience:From 2015 till now as Assistant to the President of Livzon Pharmaceutical Group, General Manager of Research and Development Department of Livzon Headquarters, and Factory Deputy Director of Livzon Pharmaceutical
Since he started working at the Group, Mr. Kong has taken on a number of different roles in production and R&D departments, and gained a wealth of basic knowledge on production technology. In his roles, he ever held responsibility for marketing Shenqi Fuzheng Injection; conducting negotiation and assessment for major projects of new drugs such as Ilaprazole and Gemifloxacin; advancing the establishment and operation of the intellectual property departments at the Joincare Pharmaceutical Group Industry Co., Ltd. and its subsidiary Livzon Pharmaceutical Group; carrying out R&D of various products like Shenqi Fuzheng Injection and Yilian (Ilaprazole Enteric-Coated Tablets). Meanwhile, he also participated in the research and development of the Ilaprazole injection which is China's first and world's sixth proton pump inhibitor. Now, this product has successfully obtained the production approval and gone on sale.
